These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 11502187

  • 1. Membrane binding and self-association of alpha-synucleins.
    Narayanan V, Scarlata S.
    Biochemistry; 2001 Aug 21; 40(33):9927-34. PubMed ID: 11502187
    [Abstract] [Full Text] [Related]

  • 2. Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins.
    Uversky VN, Li J, Souillac P, Millett IS, Doniach S, Jakes R, Goedert M, Fink AL.
    J Biol Chem; 2002 Apr 05; 277(14):11970-8. PubMed ID: 11812782
    [Abstract] [Full Text] [Related]

  • 3. Lipid interaction of alpha-synuclein during the metal-catalyzed oxidation in the presence of Cu2+ and H2O2.
    Lee EN, Lee SY, Lee D, Kim J, Paik SR.
    J Neurochem; 2003 Mar 05; 84(5):1128-42. PubMed ID: 12603836
    [Abstract] [Full Text] [Related]

  • 4. Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes.
    Davidson WS, Jonas A, Clayton DF, George JM.
    J Biol Chem; 1998 Apr 17; 273(16):9443-9. PubMed ID: 9545270
    [Abstract] [Full Text] [Related]

  • 5. Alpha-synuclein has a high affinity for packing defects in a bilayer membrane: a thermodynamics study.
    Nuscher B, Kamp F, Mehnert T, Odoy S, Haass C, Kahle PJ, Beyer K.
    J Biol Chem; 2004 May 21; 279(21):21966-75. PubMed ID: 15028717
    [Abstract] [Full Text] [Related]

  • 6. Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein.
    Li J, Uversky VN, Fink AL.
    Biochemistry; 2001 Sep 25; 40(38):11604-13. PubMed ID: 11560511
    [Abstract] [Full Text] [Related]

  • 7. Structure of membrane-bound alpha-synuclein studied by site-directed spin labeling.
    Jao CC, Der-Sarkissian A, Chen J, Langen R.
    Proc Natl Acad Sci U S A; 2004 Jun 01; 101(22):8331-6. PubMed ID: 15155902
    [Abstract] [Full Text] [Related]

  • 8. Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein.
    Jo E, Fuller N, Rand RP, St George-Hyslop P, Fraser PE.
    J Mol Biol; 2002 Jan 25; 315(4):799-807. PubMed ID: 11812148
    [Abstract] [Full Text] [Related]

  • 9. Dependence of alpha-synuclein aggregate morphology on solution conditions.
    Hoyer W, Antony T, Cherny D, Heim G, Jovin TM, Subramaniam V.
    J Mol Biol; 2002 Sep 13; 322(2):383-93. PubMed ID: 12217698
    [Abstract] [Full Text] [Related]

  • 10. alpha-Synuclein-synaptosomal membrane interactions: implications for fibrillogenesis.
    Jo E, Darabie AA, Han K, Tandon A, Fraser PE, McLaurin J.
    Eur J Biochem; 2004 Aug 13; 271(15):3180-9. PubMed ID: 15265037
    [Abstract] [Full Text] [Related]

  • 11. The synucleins.
    George JM.
    Genome Biol; 2002 Aug 13; 3(1):REVIEWS3002. PubMed ID: 11806835
    [Abstract] [Full Text] [Related]

  • 12. alpha-Synuclein membrane interactions and lipid specificity.
    Jo E, McLaurin J, Yip CM, St George-Hyslop P, Fraser PE.
    J Biol Chem; 2000 Nov 03; 275(44):34328-34. PubMed ID: 10915790
    [Abstract] [Full Text] [Related]

  • 13. Synucleins in synaptic plasticity and neurodegenerative disorders.
    Clayton DF, George JM.
    J Neurosci Res; 1999 Oct 01; 58(1):120-9. PubMed ID: 10491577
    [Abstract] [Full Text] [Related]

  • 14. alpha-Synuclein interacts with phospholipase D isozymes and inhibits pervanadate-induced phospholipase D activation in human embryonic kidney-293 cells.
    Ahn BH, Rhim H, Kim SY, Sung YM, Lee MY, Choi JY, Wolozin B, Chang JS, Lee YH, Kwon TK, Chung KC, Yoon SH, Hahn SJ, Kim MS, Jo YH, Min DS.
    J Biol Chem; 2002 Apr 05; 277(14):12334-42. PubMed ID: 11821392
    [Abstract] [Full Text] [Related]

  • 15. Mutations in the lipid-binding domain of alpha-synuclein confer overlapping, yet distinct, functional properties in the regulation of dopamine transporter activity.
    Wersinger C, Prou D, Vernier P, Niznik HB, Sidhu A.
    Mol Cell Neurosci; 2003 Sep 05; 24(1):91-105. PubMed ID: 14550771
    [Abstract] [Full Text] [Related]

  • 16. Structural transformation and aggregation of human alpha-synuclein in trifluoroethanol: non-amyloid component sequence is essential and beta-sheet formation is prerequisite to aggregation.
    Li HT, Du HN, Tang L, Hu J, Hu HY.
    Biopolymers; 2002 Aug 05; 64(4):221-6. PubMed ID: 12115139
    [Abstract] [Full Text] [Related]

  • 17. Engineered alpha-synuclein prevents wild type and familial Parkin variant fibril formation.
    Sode K, Usuzaka E, Kobayashi N, Ochiai S.
    Biochem Biophys Res Commun; 2005 Sep 23; 335(2):432-6. PubMed ID: 16081040
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Metal-catalyzed oxidation of alpha-synuclein in the presence of Copper(II) and hydrogen peroxide.
    Paik SR, Shin HJ, Lee JH.
    Arch Biochem Biophys; 2000 Jun 15; 378(2):269-77. PubMed ID: 10860544
    [Abstract] [Full Text] [Related]

  • 20. Alpha-synuclein oligomerization: a role for lipids?
    Welch K, Yuan J.
    Trends Neurosci; 2003 Oct 15; 26(10):517-9. PubMed ID: 14522142
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.